Central Glass (4044) Q2 2027 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2027 earnings summary
12 Nov, 2026Executive summary
H1 FY2027 net sales rose 19.5% YoY to ¥79,383m; operating profit reached ¥9,467m and parent-attributable profit was ¥7,274m.
Results exceeded the August forecast, supported by specialty-gas price revisions, stronger Applied Chemicals shipments, and growth in Electronic Materials, Energy Materials and Glass.
Financial highlights
Ordinary profit was ¥9,340m, up 173.7% YoY; basic EPS was ¥293.41 versus ¥86.17 a year earlier.
Gross profit increased to ¥23,858m from ¥16,495m; comprehensive income was ¥12,000m, including ¥3,673m in securities valuation gains.
Versus the August forecast, operating profit exceeded by ¥3.3bn, parent profit by ¥3.1bn and sales by ¥0.4bn.
R&D expenses were ¥3,769m, down 2.0% YoY.
Outlook and guidance
FY2027 forecast: net sales ¥171,000m, operating profit ¥16,000m, ordinary profit ¥16,200m, parent-attributable profit ¥12,500m and EPS ¥504.15.
Versus August, guidance increased by ¥3.5bn for sales, ¥5.0bn for operating profit, ¥4.9bn for ordinary profit and ¥4.5bn for parent profit.
Electronic Materials sales forecast was cut ¥3.4bn to ¥34.0bn on Q3 order adjustments and sourcing changes, while operating profit guidance rose ¥1.6bn to ¥7.0bn.
H2 Electronic Materials operating profit is expected to fall temporarily by ~¥2.0bn, primarily due to order adjustments; Energy Materials' full-year operating loss forecast widened to ¥2.9bn.
Life & Healthcare guidance rose on lower raw-material costs and stronger HFO and agrochemical-related sales; Glass guidance rose on price revisions.
Latest events from Central Glass
- New semiconductor materials support a ¥470億 FY2030 sales target.4044
Investor update - Higher H1 sales masked sharp profit declines, prompting lower FY2023 guidance.4044
Q2 2023 - Sales growth was offset by lower operating profit and net income.4044
Q1 2023 - FY2023 beat profit forecasts, but FY2024 earnings are expected to retreat.4044
Q4 2023 - Stronger glass sales could not offset lower chemical earnings and reduced extraordinary income.4044
Q3 2023 - Sales fell 10.7%, but operating profit rose on LCM support; FY guidance was unchanged.4044
Q1 2024 - Weak demand cut nine-month results and FY2024 forecasts; the ¥170 dividend was maintained.4044
Q3 2024 - H1 earnings fell on weaker demand and a share-sale loss; FY guidance was unchanged.4044
Q2 2024 - FY2025 sales edge higher, but operating profit falls amid weak demand and tariffs.4044
Q4 2024